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Bone marrow-derived mesenchymal stem cells (BMSCs) have been demonstrated ameliorating neurologic deficits after stroke. 
Hypoxia-inducible factor-1 (HIF-1), the key regulator of cellular responses to low oxygen concentration, can activate multiple 
genes involving in crucial aspects for neurologic recovery. In this study, we present that rat BMSCs overexpression of HIF-1 
showed higher expression of HIF-1 target genes in HIF-1-BMSCs, including CXCR4, EPO, and VEGF. BMSCs-mHIF-1 also 
exhibited an enhanced mobility towards the ischemic area within rat brain. Neural cell apoptosis in ischemic brain shown less 
severe in rats transplanted with HIF-1-BMSCs. Furthermore, the number of cells expressing neural progenitor markers PAX6 and 
DCX were increased in BMSCs-mHIF-1-transplanted rats. These results suggest that HIF-1 in BMSCs reduces neuronal apop-
tosis and promotes neurogenesis after stroke in rats.  
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As a leading cause of death and disability worldwide, stroke 
is still an unresolved clinical problem. In experimental stroke, 
bone marrow-derived mesenchymal stem cells (BMSCs), 
administered locally or systemically, have been demon-
strated to migrate to the ischemic hemisphere, and thereby 
promote neurologic and functional recovery [1,2]. In vitro 
study, BMSCs can be induced into both neurons and glia [3]. 
However, the mechanisms responsible for the therapeutic 
effects of BMSCs remain unclear. Several factors, such as 
transdifferentiation, induction of angiogenesis, neurogenesis 
and activation of endogenous neurorestorative processes, 
might contribute to the benefits of BMSCs in the ischemic 
brain [4]. Notably, when 2×106 BMSCs are transplanted in 
the ischemic hemisphere in the range of 0.02%, very rare 
grafted BMSCs are observed to express neural markers [2]. 
In addition, expression of neural markers may not nece-      
ssarily represent the true neural differentiation and function. 
Therefore, it appears unlikely that BMSCs would differenti-
ate in situ into the lost neural cells and integrate into neural 
connections. The more likely mechanism would be that 
BMSCs provide injured and damaged tissues an “attractive” 
microenvironment through the secretion of cytokines and 
trophic factors to activate endogenous brain remodeling. 
This process may include neurogenesis, angiogenesis, and 
synaptogenesis, reducing neuronal apoptosis and promoting 
neuronal proliferation in the boundary zone of the ischemic 
hemisphere. However, these possible therapeutic potentials 
remains to be discovered and subsequently further under-
sood. Many studies suggest genetic modification of BMSCs 
to improve therapeutic potential of BMSCs treatment on 
stroke. Indeed, overexpression of trophic factors such as 
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BDNF, FGF-2 and HGF in gene-modified BMSCs has been 
demonstrated to improve neurologic outcomes in animal 
models of ischemic stroke [5–7].   
Hypoxia plays an important role in the pathophysiology 
of ischemic brain injury. Hypoxia-inducible factor-1 (HIF-1), 
as a crucial regulator of the cellular response to low oxygen 
concentration, activates the transcription of a number of 
genes that code for proteins involving in angiogenesis, glu-
cose metabolism, cell proliferation and migration [8–10]. 
HIF-1 is a heterodimeric protein that consists of a constitu-
tively expressed HIF-1 subunit and a functional HIF-1 
subunit. Under hypoxic conditions, HIF-1 degradation is 
inhibited and dimerizes with the HIF- subunit forming the 
active HIF-1 complex to activate target genes. The central 
role of HIF-1 in the cellular response to hypoxia makes this 
factor an attractive therapeutic target for ischemic stroke. 
Recently, it is reported that HIF-1 induced-VEGF overex-
pression in bone marrow stem cells protect cardiomyocytes 
against ischemia [11]. A growing body of evidences has 
shown that HIF-1 stimulates several neurogenic, protective 
and neurotrophic activities, including proliferation of astro-
cytes [12] and microglia [13]. In a way, HIF-1 can serve as 
a neurotrophic, neuroprotective and neuroproliferative fac-
tor. This raises the possibility that HIF-1 plays essential 
roles in BMSC-mediated promotion of neurological and 
functional recovery in ischemic brain.  
In the present study, we intravenously transplanted 
BMSCs, in which a stable form of HIF-1 gene was trans-
ferred with lentivirus vector ex vivo, into rats with a perma-
nent middle cerebral artery occlusion (MCAO) model. We 
specifically intended to address the question whether over-
expression of HIF-1 could promote BMSCs therapeutic 
effect under normoxic and hypoxic conditions. Then inves-
tigated whether such a combined therapy could improve the 
therapeutic effects of BMSCs on ischemia and explored the 
possible roles of HIF-1 in mediating BMSCs migration, 
reducing neuronal apoptosis and promoting neurogenesis. 
1  Materials and methods 
1.1  Animals and the pMCAO Model 
Male healthy Sprague–Dawley rats (weighing 220–250 g) 
were obtained from the Experimental Animal Center of Sun 
Yat-Sen University and randomly divided into three groups: 
the HIF-1-BMSCs (n=18), EGFP-BMSCs (n=18), and the 
control group (n=18). The animals were kept in a standard 
light/dark schedule with free access to food and water. All 
animal procedures were conducted in compliance with the 
guidelines of the Institutional Animal Care and Use Com-
mittee. Permanent middle cerebral artery occlusion was 
induced by a modification of intraluminal vascular occlu-
sion method as previously described [14,15]. Briefly, the 
animals were anesthetized with 10% chloral hydrate (0.4 
g/kg, i.p.), the left common carotid artery, external carotid 
artery (ECA), and internal carotid artery (ICA) were exposed 
through a ventral midline incision in the neck. A silicone- 
coated nylon filament at the diameter of 0.234 mm, with its 
tip rounded by heating near flame, was introduced from the 
ECA into the lumen of the ICA until it blocked the origin of 
the MCA. 
1.2  Isolation and culture of BMSCs 
BMSCs were isolated by the density gradient technique as 
described previously [16]. In brief, the bone marrow was 
obtained from the femurs and tibias taken from male Spra-
gue-Dawley rats weighting 60−80 g. The bone marrow 
mononuclear cells were separated over Ficoll-Hypaque gra-
dients (Sigma Chemical Co., St. Louis, MO, USA) at 400×g 
for 30 min and plated into 25 cm2 flasks in Iscove’s modi-
fied Dulbeccomedium: Nutrient Mixture F-12 (GIBCO, 
BRL, Grand Island, USA) supplemented with 10% fetal 
bovine serum (Kibbutz Beit Haemek, Israel). After the cells 
were incubated at 37°C in 5% CO2 for 3 d, the culture me-
dium containing non-adherent cells was removed, and the 
adherent layer was washed once with the fresh medium and 
then cultured continuously. After the cells reach 80% con-
fluence, they were incubated at 1:3 dilutions. BMSCs were 
used for intravenous transplantation in these experiments.  
1.3  HIF-1 mutagenesis  
A full length cDNA of human HIF-1 was obtained by 
PCR and cloned in pcDNA3.0 (Invitrogen Corp., Carlsbad, 
CA, USA), which was used as a template for PCR to induce 
site-directed mutation at residues P402, P564 and N803 that 
target HIF-1 for proteosomal degradation under normoxic 
conditions [17]. The synthesized primers were: P402A 
(CCA→GCA), GCTTTAACTTTGCTGGCCGCAGCCGC-     
TGGAGACACA (forward) and TGTGTCTCCAGCGGC-     
TGCGGCCAGCAAAGTTAAGC (reverse); P564G (CCC
→GGC), CTTGGAGATGTTAGCTGGCTATATCCCAA-      
TGGATG (forward) and CATCCATTGGGATATAGCCA-    
GCTAACATCTCCAAG (reverse); N803A (AAT→GCT), 
CCAGTTATGATTGTGAAGTTGCTGCTCCTATACAA-      
GGCAG (forward) and CT GCCTTGTATAGGAGCAGC-      
AACTTCACAATCATAACTGG (reverse). The triple muta-
tions of HIF-1 cDNA were verified by DNA sequencing.   
1.4  Lentivirus vector construction   
The triple mutant HIF-1 fragment was sub-cloned into 
pEGFP-N2 vector (Clontech, Palo Alto, CA, USA) via KpnI 
and BamHI sites to generate the mHIF-1-EGFP fusion 
gene expression plasmid (pEGFP-N2/mHIF-1). The cod-
ing sequences of mHIF-1-EGFP and EGFP were amplified 
from the above pEGFP-N2/mHIF-1 plasmid and TOPO 
cloned into vector pENTR/D-TOPO, and then transferred 
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into plenti6/v5-DEST by using the Gateway LR recombina-
tion reaction (Invitrogen). Lentiviral expression plasmids 
containing mHIF-1-EGFP sequence and EGFP sequence 
were termed Lv-mHIF-1-EGFP and Lv-EGFP, respec-
tively. The integrity of plasmids were identified by restriction 
enzyme analysis and confirmed by DNA sequencing.   
1.5  Lentivirus production and infection of BMSCs    
Recombinant lentiviruses were produced by cotransfection 
of 293T cells with the packaging plasmids (pLP1, pLP2, 
and pLP/VSVG) and lentivirus expression plasmids (Lv- 
mHIF-1-EGFP or Lv-EGFP), using the Lipofectamine 
2000 reagent (Invitrogen). The virvus-containing superna-
tant was harvested 48 h posttransfection and filtered through 
a Millex HV filter (0.45 m, Millipore Corp). BMSCs were 
infected with the lentivirus in the presence of 5 g/mL 
Polybrene (Sigma-Aldrich, Steinheim, Germany). Stable 
transfectants were selected in 50 g/mL Blasticidin for 14 d. 
BMSCs infected with Lv-HIF-1-EGFP were named BMSCs- 
mHIF-1, and BMSCs infected with Lv-EGFP were named 
BMSCs-EGFP.  
1.6  Behavioral tests 
All animals were received a modified neurological severity 
score (mNSS) tests before MCAO and 1, 7, 14 and 28 d 
post MCAO (n=6 for each group). Neurological function 
was graded on a scale of 0−18, with normal score as 0 and 
maximal deficit score 18. In the severity scores of injury, 
the higher the score, the more severe the neurological deficit. 
Spatial learning and memory was assessed using a modified 
version of the Morris water-maze test [18]. Briefly, the rats 
were placed in a circular tank of warm, opaque water with a 
hidden platform. During training trials, latency to find the 
platform location is recorded. During probe trials, the plat-
form is removed, and the percentage of time spent in the 
quadrant that normally contains the platform is compared to 
the time spent in other quadrants. 
1.7  Intravenous administration of BMSCs  
In vivo study, the experimental groups consisted of control 
group: rats were given MCAO without cell administration 
but with 1 mL PBS; BMSCs-EGFP group: rats were trans-
planted with 2×106 BMSCs-EGFP; BMSCs-mHIF-1 group: 
rats received BMSCs-mHIF-1 (2×106 cells) via intrave-
nously injection at 3 h after MCAO. All the transplantation 
procedures were performed under aseptic conditions.   
1.8  Cerebral infarct measurement  
Cerebral infarct volume was measured by staining brain 
slices with triphenyltetrazolium chloride (TTC; Sigma, St. 
Louis, MO, USA) 7 d after MCAO. The animals (n=3 for 
each group) were decapitated under deep anesthesia with 
10% chloral hydrate (0.8 g/kg, i.p.) The brains were quickly 
removed and sliced into 5 coronal sections at 3-mm inter-
vals. The slices were incubated in a 2% solution of TTC at 
37°C for 30 min and then fixed in 10% formaldehyde solu-
tion overnight. The infarct area of each brain slice was ana-
lyzed using the Image-Pro plus 5.0 analysis software. The 
total infarct volume for each brain was calculated by sum-
mation of the infarct area of all brain slices.  
1.9  Semi-quantitative RT-PCR  
Total RNA was extracted from BMSCs and brain biopsy 
tissues using TRIzol reagent (Invitrogen) according to the 
manufacturer’s protocol. The first strand of cDNA was ob-
tained using Revert Aid First Strand cDNA Synthesis Kit 
(MBI, Norwalk, CT, USA). PCR was performed with rTaq 
polymerase (TaKaRa, Japan). The cycling conditions used 
were: denaturing at 94°C for 5 min, annealing at 60°C for 1 
min, and polymerization at 72°C for 1 min. The resulting 
PCR products were analyzed by 1.5% agarose electropho-
retic gels using DL2000 DNA Marker (TaKaRa) as a size 
reference. Gel images were obtained and the densities were 
quantified with the application Bio-ID gel analysis software 
(Vilber Lourmat, Marne-la-Vallée, France). All results rep-
resented the average density of positive bands obtained 
from at least three independent experiments.   
1.10  Western blot  
Fresh tissue samples of ischemic hemisphere, obtained at  
7 d after MCAO, were homogenized for western blot study. 
After lysis and evaluation of protein content via Bradford 
protein assay, equal amounts of protein were separated by 
SDS-PAGE and transferred to PVDF membrane (0.45-m 
pore size, Roche Molecular Biochemicals, South San Fran-
cisco, CA, USA). The blocked membranes were then incu-
bated with different antibodies overnight at 4°C: mouse 
anti-HIF-1 (1:1000; Chemicon). After washing with TBST, 
the membranes were incubated with HRP-conjugated anti-
body (1:2000; Amersham) for 60 min at 37°C, and then 
detected with ECL (Amersham). The optical density of the 
bands was quantified by Bio-Rad Image analysis.   
1.11  TUNEL   
DNA strand breaks were detected using TUNEL method. 
Briefly, brain sections were deparaffinized and digested with 
proteinase K (Roche) and then covered with TUNEL reac-
tion mixture, followed by converter-POD/wash buffer. Final-
ly, sections were covered with AEC substrate solution and 
detected with diaminobenzidine (DAB, Chemicon ES005- 
10 ML). The integrated optical density (IOD) of apoptotic 
neuronal cells was measured in the cortex and hippocampus 
of ipsilateral hemisphere using light microscope (Olympus 
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BH2-RFL-T3 Japan 400×) and color image recorder (JVC 
KY F30B 3-CCD Germany) and analyzed using Pro Plus 
software 5.1 (Media Cybernetics, Bethesda, MD, USA) by 
the protocol. The neuronal apoptosis from at least three sec-
tions per animal selected randomly was evaluated immuno-
histochemically to determine IOD of the apoptotic cells 
exhibiting positive staining. For each slide, 6 fields were 
selected and examined randomly, in a defined rectangular 
field area (×200 objective), a total of at least 2000 cells per 
field were counted. The apoptotic index was determined 
(i.e., IOD of apoptotic cells divided bythe total neuronal 
cells counted ×200) from a total of 18 fields per brain. The 
assays were performed in a double-blinded manner.  
1.12  Immunofluorescence  
Immunofluorescent evaluation was performed on rat brain 
samples collected at day 1, 7, 14, following the intravenous 
transplantation of BMSCs into rats subjected to MCAO. For 
double fluorescence labeling of Pax6/DCX in the hippo-
campus region at day 7 and cortex at day 14 post MACO, 
respectively. Sections were incubated with primary anti-
bodies: mouse anti-Pax6 (1:300; Chemicon); goat anti-DCX 
(1:400) (Santa Cruz, CA, USA), respectively. After wash-
ing with PBS, the sections were incubated with the appro-
priate fluorescent secondary antibodies for 1 h at 37°C. 
Negative control sections from each animal received identi-
cal preparations for immunofluorescence staining, except that 
the primary antibodies were omitted. The sections were 
examined with an IX71 SIF-2 fluorescence microscope for 
fluorescence equipped with an Olympus digital camera/ 
Image-Pro plus software 5.1. For each section, six micro-
scope fields in a defined rectangular field area (×200 objec-
tive) were selected and analyzed randomly. Cells were 
counted in images captured from these areas.  
1.13  Statistical analysis  
The measurements were performed blindly. SigmaStat (SPSS, 
Inc., Chicago, Illinois, USA) statistical software was used 
for all statistical analysis. All data represented at least three 
independent experiments and statistical differences between 
the means for the different groups were evaluated with a one- 
way analysis of variance (ANOVA). Results are expressed 
as mean ± SD. P <0.05 was set as statistical significance.  
2  Results 
2.1  Lentivirus-mediated constitutive expression of 
HIF-1 in BMSCs  
In order to induce stable expression of HIF-1, BMSCs 
were infected with lentivirus encoding the triple mutant 
form HIF-1, in which site-directed mutation at residues 
P402, P564 and N803 leads to stabilization of HIF-1 in 
normoxia (Figure 1(a)). Semi-quantitative RT-PCR showed  
 
Figure 1  Lentivirus-mediated constitutive expression of HIF-1 in BMSCs. (a) Aschematic illustrating the location of the three point mutations in relation 
to the various domains of the HIF-1 triple mutant protein. (b) RT-PCR analysis of mRNA isolated from BMSCs 48 h post-transfection BMSCs-mHIF-1 
group or BMSCs-EGFP. (c) Statistical analysis of RT-PCR. (d) Western blot analysis of protein isolated from BMSCs 48 h post-transfection BMSCs- 
mHIF-1 group BMSCs-EGFP or control. * indicates P <0.05. 
 Ye Z Z, et al.   Chin Sci Bull   October (2013) Vol.58 No.28-29 3523 
that the expression level of HIF-1 mRNA was strongly 
induced in BMSCs-mHIF-1. Interestingly, the mRNA level 
of the HIF-1 target genes VEGF, EPO and CXCR4 were 
also found significantly increased (Figure 1(b)(c)). Western 
blot analysis further confirmed a strong up-regulation of 
HIF-1 in BMSCs-mHIF-1 (Figure 1(d)). Even the cells 
were cultured in nomoxia, HIF-1 was hardly detectable in 
non-transduced cells.  
2.2  Neurologic outcome 
Only moderate and severely injured rats (mNSS>6) were 
included in subsequent experiments (>90% of rats in each 
group). No significant difference was detected among all 
the groups prior to surgery and before treatment. The rats 
treated with BMSCs-mHIF-1 had significant functional 
recovery on mNSS when compared with the control group 
rats from day 7 after MCAO. However, the significant neu-
rological functional recovery was observed in the BMSCs- 
EGFP group 1 compared with the sham-group rats 14 d af-
ter MCAO. When time was going by day 14 and 28, the 
significant recovery in BMSCs-mHIF-1 was observed when 
compared with either the BMSCs-EGFP or the control 
groups (Figure 2). Furthermore, as tested in the Morris Water- 
Maze test at both day 14 and 28 post MCAO, the latency 
periods and travel distances in two BMSC-treated group rats 
were all significantly shorter than those in the control group 
(Table 1). Under these circumstances, there was no signifi-
cant difference observed between the two BMCS-treated 
groups.  
 
Figure 2  Cerebral infarct volumes of rats 7 days after MCAO. (a) TTC staining of brain slices. (b) A tendency of infarct volume decreased in HIF-1- 
BMSCs-treated rats was noticed. Significant reductions of infarct volume in BMSCs-mHIF-1 group rats were observed when compared with the control or 
the BMSCs-EGFP group (*P <0.05). 
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2.3  Quantitative analysis of infarct volume  
Infarct volumes were determined from TTC-stained sequen-
tial coronal sections of experimental rats. While there was a 
tendency for infarct volume to decrease in the BMSCs- 
mHIF-1 group as detected 1 d after MCAO, this difference 
was not statistically significant. At day 7, there were signif-
icant reductions of infarct volume in rats of the BMSCs- 
mHIF-1 group compared with the BMSCs-EGFP group 
and the control group, respectively (Figure 2).  
2.4  Migration of transplanted BMSCs in ischemic brain  
Immunofluorescent evaluation was performed on rat brain 
samples collected at day 1, 7, 14, following the intravenous 
transplantation of BMSCs into rats subjected to MCAO. 
GFP-labeling of BMSCs facilitated tracking the transplant-
ed cells by fluorescent microscopy. One day after cell infu-
sion, the majority of BMSCs were initially localized within 
the olfactory area surrounding the occlusion point of the 
middle cerebral artery, which could be defined as the is-
chemic core. At day 7 after transplantation, BMSCs were 
found to have entered the boundary area of the injured cor-
tex, mainly including hypothalamus, thalamus and internal 
ventricle. At later time points of day 14, the majority of 
transplanted cells were distributed in the striatum and motor 
cortex fields adjacent to the infarct region (Figure 3).  
2.5  mHIF-1-transduced BMSCs reduce neuronal 
apoptosis in ischemic tissue  
Overall, many apoptotic neuronal cells could be detected by 
TUNEL staining in cortex and hippocampus of all experi-
mental rats 1 d after MCAO. However, the number of apop-
totic cells (P<0.01) in hippocampus of the BMSCs-mHIF-1 
rats were found significantly less than that of the other two 
groups at day 7 after MCAO (Figure 4). 
2.6  mHIF-1-Transduced BMSCs induced neurogenesis 
in ischemic tissue  
Doublecortin (DCX) is an important neuronal microtubule- 
associated protein, which can be used as the migration marker 
of immature neurons. Individual adult neural stem cells can  
Table 1  The comparison of acquisition performance on the Morris Water-Maze test among the three group rats (n=6)a) 
Time (d) 
Control  BMSCs-EGFP  BMSCs-mHIF-1 
Escape latency (s) Path length (cm)  Escape latency (s) Path length (cm)  Escape latency (s) Path length (cm) 
14 101.5±10.6* 1872.3±68.6* 35.8±5.9 612.1±33.4  25.3±3.1 523±23.6 
28 108.5±12.8* 1902.3±98.6* 28.0±4.1 349.6±31.8  18.3±4.2 256±23.1 
a) The above escape latency (s) and path length (cm) of rats in the Morris Water-Maze indicated that ischemia-induced spatial learning and memory defi-
cits were significantly ameliorated in both BMSCs-mHIF-1 group and BMSCs-EGFP group compared with control group at 14 and 28 d after transplanta-
tion. Values are mean±SD, and analyzed with one-way ANOVA. * P<0.05. 
 
Figure 3  Presence of GFP+ cells in the rat brain at different time points post MCAO. (a) At day 1, the majority of GFP+ cells were confined to the olfac-
tory area, belonging to the infarct core. At day 7, abundant GFP+ cells are detected in the boundary area of the injured cortex, which mainly includes hypo-
thalamus, thalamus and internal ventricle. At day 14, the majority of GFP+ cells were distributed in the striatum and motor cortex fields adjacent to the in-
farct region. (b) The GFP+ cell distribution delineated by arrow suggesting the migrate route of transplanted BMSCs. Scale bar, 100 m.  
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highly express pax6, Emx2, and Mash1 transcription factors, 
which can also be identified different subtypes of neural 
progenitor cells. Pax6/DCX positive cells indicate neuro-
blast. Immunohistochemitry with two monoclonal antibod-
ies specific to immature neuron (pax6 and DCX) were em-
ployed to identify the endogenous neural stem cells (NSCs). 
It was demonstrated that the pax6/DCX double positive 
cells were mainly present in hippocampus and penumbral 
regions of cortex. The number of pax6/DCX cells was ac-
counted in six randomly selected locations of cortex and 
hippocampus. A significant increase of pax6/DCX cells in 
hippocampus was found in the BMSCs-mHIF-1 group at 
day 7 post MCAO (Figure 5(a)). Meanwhile, the higher 
number of pax6/DCX cells were also found in cortex of 
BMSCs-mHIF-1 group rats at day 14 after MCAO (Figure 
5(b)). These results indicated that the mHIF-1-transduced 
BMSCs injection enhanced the neuronal proliferation in the 
hippocampus and cortex post MCAO.  
3  Discussion 
Stroke is characterized by the interruption of blood flow to 
the brain, which initiates a series of complex events that 
cause neuronal death and neurological deficits. Recent studies 
have demonstrated that neurogenesis occurs throughout 
adulthood and that neural stem cells reside in the adult cen-
tral nervous system (CNS) [19]. The survival, proliferation, 
migration and differentiation of neural stem cells are regu-
lated by a variety of endogenous and exogenous factors, 
including oxygen concentration [20], growth factors [21–24] 
and cytokines [25,26]. Some of these factors have been 
confirmed to guide stem cells to the state where they can 
improve the functional recovery of brain tissue after stroke 
[27]. Meanwhile, intravenous administration of BMSC has 
been demonstrated to improve neurological deficits and ac-
celerate their recovery in a rat model of stroke. Application of 
BMSCs in clinical trials further showed positive results and 
no side effects were detected. This study provides additional 
supportive evidences to the earlier conclusion that admin-
istration of BMSCs could significantly promote morpho-
logical and functional recovery. Although the therapeutic 
mechanisms remained to be clarified, induction of neuro-
genesis by means of transplanting BMSCs in ischemic brain 
may contribute to functional improvement of brain, as it has 
been suggested that BMSCs may stimulate the adjacent host  
 
Figure 4  Apoptotic cells present in rat brain as detected by TUNEL-staining. (a) TUNAL-staining at day7 post MCAO, respectively. (b) Photographs for 
cortex and hippocampus tissues of TUNEL-staining and the lower panels show the counting of TUNEL-stained cells. *P <0.01.  
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Figure 5  Pax6 and DCX expression in the ischemic tissues of rat brain. Double immunofluorescent staining in the hippocampus region at day 7 (a) and 
cortex at day 14 (b) post MACO, respectively. In both the shown tissue regions, a significant increase of pax6/DCX double positive cells was observed in 
BMSCs-mHIF-1 group rats at 7 d after MCAO (*P<0.05). Scale bar, 100 m.  
cells by producing trophic, proangiogenic and other para-
crine factors.  
Recent studies have shown that overexpression of HIF-1 
could drive a potent paracrine activity and subsequently 
elevate the levels of growth factors and cytokines [28–30], 
which suggested that HIF-1 may be one of the potential 
regulators for the treatment of brain ischemia. In our study, 
intravenous administration of BMSCs-mHIF-1 could im-
prove the neurological restoration and significantly reduce 
the infarction volume in a rat model of stroke. Furthermore, 
constitutive expression of HIF-1 could enhance the migra-
tion of BMSCs toward ischemic cerebral hemisphere, re-
duce neuronal apoptosis and promote neuronal proliferation. 
Although how the constitutive expression of HIF-1 act on 
BMSCs remains unknown, the result that expression of the 
four HIF-1 target genes, including EPO, VEGF and CXCR4, 
were upregulated in our study do bring us some clues to an-
swer these questions. Therefore, the positive roles of HIF-1 in 
the regeneration of brain tissue might be via these molecules. 
Currently the roles of HIF-1 in the progression of cere-
bral ischemia appear controversial [31,32]. A number of 
previous studies clearly indicated that activation of HIF-1 is 
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a central part of adaptive responses to attenuate the harmful 
effects of ischemic brain injury. Particularly, HIF-1 up-
regulation by hypoxia pre-conditioning has been shown to 
be neuroprotective against cerebral ischemia [32,33]. HIF-1 
regulates the transcription of many well-established neuro-
protective genes in response to hypoxia, which is of crucial 
importance in governing essential steps of neurogenesis, 
including cell survival, migration, proliferation and differ-
entiation. In normoxia, HIF-1 is hydroxylated on Pro-402 
and Pro-564 in the oxygen-dependent degradation domain 
(ODD) by EGLN1/PHD1 and EGLN2/PHD2. The hydrox-
ylated prolines promote interaction with VHL, initiating 
rapid ubiquitination and subsequent proteasomal degrada-
tion. This hydroxylation is inhibited by the Cu/Zn chelator- 
Clioquinol. S-nitrosylation of Cys-800 may be responsible 
for increased recruitment of p300 coactivator necessary for 
transcriptional activity of HIF-1 complex requiring phos-
phorylation for DNA binding. HIF-1 transcription, as a pri-
mary determinant of embryonic morphogenesis, is essential 
for normal brain development [34,35]. Targeted disruption 
of HIF-1 results in severe cardiac and vascular malfor-
mation leading to embryonic lethality by day 10.5 of gesta-
tion [8]. Conditional inactivation of HIF-1 gene in mid-
brain-derived neural precursor cells (mNPC) indicates that 
HIF-1 is required for the proliferation and survival of pre-
cursor cells. These studies support the conclusion that 
HIF-1 has beneficial roles in neuroprotection. However, 
some other studies suggest that activation of HIF-1 signal-
ing may have a harmful effect on ischemic brain [36−38]. In 
vivo HIF-1 knockout studies showed that deletion of 
HIF-1 in the brain led to an amelioration of apoptosis in the 
nervous system of the adult mouse [38]. HIF-1 inhibition 
after cerebral ischemia showed that decreasing the expres-
sion of HIF-1 might be neuroprotective [36,37]. Therefore, 
clarification of the detailed molecular and cellular mecha-
nisms of HIF in neuroprotection need further study. One of 
the possible explanations may be that the effects of HIF-1 
activation on ischemic brain depend on the cell types [12] 
and the duration [39]. In our present study, we demonstrated 
that constitutive expression of HIF-1 in BMSCs played pos-
itive roles, including improving cell migration, reducing 
neuronal apoptosis and promoting neuronal proliferation. 
Our results are well consistent with many drawn from pre-
vious reports. HIF-1 mediates neural progenitor cell pro-
liferation and differentiation [40,41]. More importantly, 
significant improvement in neurologic function of ischemic 
brains was further observable, which might be due to the 
constitutive expression of HIF-1 in transplanted BMSCs.  
Various molecular factors including chemokines, cyto-
kines, matrix molecules, together with their specific recep-
tors, may contribute to cell migration [42].The enhanced 
ability of mHIF-1-modulated BMSCs to migrate to the sites 
of damage was demonstrated in the present study. Among 
multiple potential factors, the SDF-1/CXCR4 axis has been 
reported to be expressed in a wide range of tissues, includ-
ing brain, heart, kidney, liver, lung, and spleen [43], which 
has been involved in several diseases such as ischemic car-
diomyopathy and brain disorders [44]. Previous studies 
have demonstrated that HIF-1 can induce SDF-1 expression 
and result in enhancing adhesion, migration and homing of 
circulating CXCR4-positive progenitor cells to ischemic 
tissue. Blockade of SDF-1 in ischemic tissue or CXCR4 on 
circulating cells prevents progenitor cell recruitment to the 
sites of injury [45]. Meanwhile, CXCR4, also a HIF-1-target 
gene, was up-regulated in mHIF-1-BMSCs and may pos-
sibly contribute to the enhanced migration of these cells.  
The hyperexpression of HIF-1 protein has been shown 
to upregulate downstream gene expression even under con-
ditions of normoxia [46]. Our data showed that BMSCs- 
mHIF-1 significantly promoted the expressions of EPO 
and VEGF, which may subsequently provide an appropriate 
microenvironment for the damaged neuronal cells to neuro-
genesis. In addition, MSCs within the ischemic brain can 
induce the production of growth factors within the paren-
chymal tissue, particularly from astrocytes, as suggested in 
a co-culture system of human NSCs with astrocytes, where 
the signal transduction cascades of cultured astrocytes can 
be altered by MSCs. Astrocytes can also express angiopoi-
etin1 and its receptor Tie2, which both can contribute to 
both angiogenesis and the maturation of newly formed ves-
sels. Furthermore, MSCs can also induce additional proan-
giogenic factors and trophic factors by endogenous endo-
thelial cells. The new and activated vessels then likely or-
chestrate further angiogenesis, attract neuroblasts to their 
locale, and enhance white matter and neurite plasticity. The 
neuroblasts, which are attracted to vessels, also subsequently 
further amplify the angiogenic response, leading to recovery.  
Taken together, our study and others demonstrated that 
the constitutive expression of HIF-1 in BMSCs improve their 
migration toward ischemic cerebral hemisphere, reduce 
neuronal apoptosis and promote neuronal proliferation after 
stroke in rats.  
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